1612 related articles for article (PubMed ID: 26181352)
21. Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.
Hamada T; Nowak JA; Masugi Y; Drew DA; Song M; Cao Y; Kosumi K; Mima K; Twombly TS; Liu L; Shi Y; da Silva A; Gu M; Li W; Nosho K; Keum N; Giannakis M; Meyerhardt JA; Wu K; Wang M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
J Natl Cancer Inst; 2019 Jan; 111(1):42-51. PubMed ID: 30312431
[TBL] [Abstract][Full Text] [Related]
22. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.
Masugi Y; Nishihara R; Hamada T; Song M; da Silva A; Kosumi K; Gu M; Shi Y; Li W; Liu L; Nevo D; Inamura K; Cao Y; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig SJ; Fuchs CS; Qian ZR; Nowak JA; Ogino S
Cancer Immunol Res; 2017 Nov; 5(11):1046-1055. PubMed ID: 29038297
[TBL] [Abstract][Full Text] [Related]
23. Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.
Kosumi K; Masugi Y; Yang J; Qian ZR; Kim SA; Li W; Shi Y; da Silva A; Hamada T; Liu L; Gu M; Twombly TS; Cao Y; Barbie DA; Nosho K; Baba H; Garrett WS; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
Oncoimmunology; 2017; 6(3):e1284720. PubMed ID: 28405513
[TBL] [Abstract][Full Text] [Related]
24. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
[TBL] [Abstract][Full Text] [Related]
25. Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.
Song M; Nishihara R; Cao Y; Chun E; Qian ZR; Mima K; Inamura K; Masugi Y; Nowak JA; Nosho K; Wu K; Wang M; Giovannucci E; Garrett WS; Fuchs CS; Ogino S; Chan AT
JAMA Oncol; 2016 Sep; 2(9):1197-206. PubMed ID: 27148825
[TBL] [Abstract][Full Text] [Related]
26. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
27.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
28. Inverse relationship between
Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S
Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192
[TBL] [Abstract][Full Text] [Related]
29. Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells.
Yang W; Liu L; Keum N; Qian ZR; Nowak JA; Hamada T; Song M; Cao Y; Nosho K; Smith-Warner SA; Zhang S; Masugi Y; Ng K; Kosumi K; Ma Y; Garrett WS; Wang M; Nan H; Giannakis M; Meyerhardt JA; Chan AT; Fuchs CS; Nishihara R; Wu K; Giovannucci EL; Ogino S; Zhang X
Cancer Prev Res (Phila); 2019 May; 12(5):283-294. PubMed ID: 30760501
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.
Mima K; Cao Y; Chan AT; Qian ZR; Nowak JA; Masugi Y; Shi Y; Song M; da Silva A; Gu M; Li W; Hamada T; Kosumi K; Hanyuda A; Liu L; Kostic AD; Giannakis M; Bullman S; Brennan CA; Milner DA; Baba H; Garraway LA; Meyerhardt JA; Garrett WS; Huttenhower C; Meyerson M; Giovannucci EL; Fuchs CS; Nishihara R; Ogino S
Clin Transl Gastroenterol; 2016 Nov; 7(11):e200. PubMed ID: 27811909
[TBL] [Abstract][Full Text] [Related]
31. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.
Kosumi K; Hamada T; Koh H; Borowsky J; Bullman S; Twombly TS; Nevo D; Masugi Y; Liu L; da Silva A; Chen Y; Du C; Gu M; Li C; Li W; Liu H; Shi Y; Mima K; Song M; Nosho K; Nowak JA; Nishihara R; Baba H; Zhang X; Wu K; Wang M; Huttenhower C; Garrett WS; Meyerson ML; Lennerz JK; Giannakis M; Chan AT; Meyerhardt JA; Fuchs CS; Ogino S
Am J Pathol; 2018 Dec; 188(12):2839-2852. PubMed ID: 30243655
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
33. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
34. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate.
Hanyuda A; Ogino S; Qian ZR; Nishihara R; Song M; Mima K; Inamura K; Masugi Y; Wu K; Meyerhardt JA; Chan AT; Fuchs CS; Giovannucci EL; Cao Y
Int J Cancer; 2016 Aug; 139(4):854-68. PubMed ID: 27037951
[TBL] [Abstract][Full Text] [Related]
35. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
[TBL] [Abstract][Full Text] [Related]
37. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
Kosumi K; Baba Y; Yamamura K; Nomoto D; Okadome K; Yagi T; Toihata T; Kiyozumi Y; Harada K; Eto K; Sawayama H; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Br J Cancer; 2023 Apr; 128(6):1155-1165. PubMed ID: 36599917
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
[TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
